Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7414

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907414)

Label Image (Lbl500907414)
This text provides information about a product with the product number 58676-0. It contains 90 tablets and the text "Kilwasrarin." The additional number 18 and z09507 may be related to the product as well. Overall, it seems to be a label or description of a product.*
FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)
This appears to be a table showing evidence related to a comparison of RSV vaccine and placebo, with data including hazard ratio, confidence interval, p-value, and number at risk over several years of observation. The hazard ratio of 0.56 at a 95% confidence interval suggests a significant difference between the RSV vaccine and placebo group, with a p-value of less than 0.001. The number at risk over the years is also provided in the table.*
FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)
This is a comparative analysis table showing the number of events related to the efficacy and safety of Roswa20mg compared to Placebo20mg in a study with 8901 participants. It includes data on primary endpoints, cardiovascular death, nonfatal stroke, nonfatal MI, hospitalizations for unstable angina, and arterial revascularization. The Hazard Ratio and significance levels (P-values) are provided for each comparison. The text also mentions that cardiovascular death includes fatal MI, fatal stroke, sudden death, and other adjudicated causes of CV death.*
FDA Label Image

Figure 3. (Rosuvastatin Fig3)

Figure 3. (Rosuvastatin Fig3)
This text is a list of different statin medications and the corresponding doses in milligrams (mg) for each medication. It also shows the percent change in LDL-C levels compared to baseline for each dose of the respective statin medication. This information can be used to compare the effectiveness of different statins at various doses in lowering LDL-C levels.*
FDA Label Image

Chemical Structure (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.